Literature DB >> 6313807

Gamma-interferon is the factor in lymphokine that activates human macrophages to inhibit intracellular Chlamydia psittaci replication.

C D Rothermel, B Y Rubin, H W Murray.   

Abstract

We have demonstrated previously that mitogen-induced lymphokines activate human monocyte-derived macrophages to inhibit the intracellular replication of Chlamydia psittaci. To identify the factor(s) in crude lymphokines responsible for this antimicrobial effect, we tested human Con A-induced lymphokines for interferon activity. We also attempted to neutralize the lymphokines with a monoclonal antibody directed against human gamma-interferon and examined the ability of partially purified human gamma-interferon to induce macrophage antichlamydial activity. The lymphokine-induced antichlamydial effect was measured by the inhibition of chlamydial inclusion formation in Giemsa-stained macrophage cultures. Our lymphokines were found to be rich in gamma-interferon; treatment of cells for 48 hr before infection with lymphokines containing 300 U/ml of interferon resulted in an 89% inhibition of chlamydial growth. This lymphokine effect was completely abolished by monoclonal antibody against human gamma-interferon, but not by antisera against human alpha- or beta-interferons. In addition, partially purified human gamma-interferon alone induced macrophages to restrict chlamydial growth by 95%. We conclude that it is the gamma-interferon present in human Con A-induced lymphokines that activates monocyte-derived macrophages to inhibit chlamydial replication.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6313807

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  58 in total

Review 1.  Chlamydial persistence: beyond the biphasic paradigm.

Authors:  Richard J Hogan; Sarah A Mathews; Sanghamitra Mukhopadhyay; James T Summersgill; Peter Timms
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

Review 2.  Interaction of chlamydiae and host cells in vitro.

Authors:  J W Moulder
Journal:  Microbiol Rev       Date:  1991-03

3.  Effects of recombinant interferon-gamma and chemotherapy with isoniazid and rifampicin on infections of mouse peritoneal macrophages with Listeria monocytogenes and Mycobacterium microti in vitro.

Authors:  M Khor; D B Lowrie; D A Mitchison
Journal:  Br J Exp Pathol       Date:  1986-10

4.  Inhibition of growth of Chlamydia trachomatis by human gamma interferon.

Authors:  Y Shemer; I Sarov
Journal:  Infect Immun       Date:  1985-05       Impact factor: 3.441

5.  Deficient immune interferon production in tuberculosis.

Authors:  J K Onwubalili; G M Scott; J A Robinson
Journal:  Clin Exp Immunol       Date:  1985-02       Impact factor: 4.330

6.  Beta interferon inhibits Toxoplasma gondii growth in human monocyte-derived macrophages.

Authors:  J L Schmitz; J M Carlin; E C Borden; G I Byrne
Journal:  Infect Immun       Date:  1989-10       Impact factor: 3.441

7.  Interferon-gamma inhibits growth of Coxiella burnetii in mouse fibroblasts.

Authors:  J Turco; H A Thompson; H H Winkler
Journal:  Infect Immun       Date:  1984-09       Impact factor: 3.441

8.  Chlamydia trachomatis-specific human CD8+ T cells show two patterns of antigen recognition.

Authors:  Malgosia K Matyszak; J S Hill Gaston
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

9.  Inhibition of Chlamydia trachomatis replication in HEp-2 cells by human monocyte-derived macrophages.

Authors:  E Manor; I Sarov
Journal:  Infect Immun       Date:  1988-12       Impact factor: 3.441

10.  Lymphokine-mediated inhibition of Chlamydia replication in mouse fibroblasts is neutralized by anti-gamma interferon immunoglobulin.

Authors:  G I Byrne; D A Krueger
Journal:  Infect Immun       Date:  1983-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.